Understanding the detailed chemical profile of intermediates is crucial for success in pharmaceutical development. NINGBO INNO PHARMCHEM CO.,LTD. is pleased to share insights into 8-Bromo-3-methyl-xanthine (CAS 93703-24-3), a compound with significant industrial relevance, particularly within the pharmaceutical sector.

8-Bromo-3-methyl-xanthine is characterized by its molecular formula C6H5BrN4O2 and a molecular weight of 245.03. Its chemical structure features a purine core with a bromine atom at the 8-position and a methyl group at the 3-position. This specific arrangement is key to its function as a pharmaceutical intermediate. The compound typically presents as a sight yellow to white powder, with a high melting point of 300°C, indicative of its stable crystalline structure. Its solubility is noted as slight in DMF and DMSO, typical for many organic intermediates of this nature.

The synthesis of 8-Bromo-3-methyl-xanthine is a carefully controlled process, often involving the bromination of 3-methylxanthine. This method ensures the selective placement of the bromine atom, which is critical for its downstream applications. At NINGBO INNO PHARMCHEM CO.,LTD., we prioritize precision in our synthesis routes to guarantee product consistency and purity, meeting the demanding requirements of pharmaceutical manufacturing.

The primary industrial application for 8-Bromo-3-methyl-xanthine is its use as a precursor in the synthesis of Linagliptin, a vital medication used in the management of type 2 diabetes. The compound's structure directly facilitates the necessary chemical reactions to build the Linagliptin molecule. Beyond this major application, it also serves as an intermediate in the research and development of other bioactive purine derivatives, potentially leading to new antiviral and anti-tumor therapies.

As a committed 8-Bromo-3-methyl-xanthine supplier in China, NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to providing researchers and manufacturers with high-quality materials. Our focus on product integrity and reliable supply chains supports the advancement of pharmaceutical science and the creation of essential medicines.